Of vaccine-autism, thimerosal, and metallothioneins
First published: 07 February 2007
No abstract is available for this article.
References
- 1
Singh VK,
Hanson J.
Assessment of metallothionein and antibodies to metallothionein in normal and autistic children having exposure to vaccine-derived thimerosal.
Pediatr Allergy Immunol
2006; 17: 291–6.
- 2
Goyer RA,
Clarkson TW.
Toxic effects of metals. In: CD Klaassen, ed. Casarett & Doull's Toxicology: The Basic Science of Poisons, 6th edn. New York: McGraw Hill, 2001: 822–6.
- 3
Pinchichero ME,
Cernichiari E,
Lopreiato J,
Treanor J.
Mercury concentration and metabolism in infants receiving vaccines containing thiomersal: a descriptive study.
Lancet
2002; 360: 1711–2.
- 4
Imm P,
Knobeloch L,
Anderson HA.
Maternal recall of children's consumption of commercial and sport-caught fish: findings from a multi-state study.
Environ Res
2006; July 7: (In press. doi:10.1016/j.envres.2006.5.011).
- 5
Magos L,
Clarkson TW.
Overview of the clinical toxicity of mercury.
Ann Clin Biochem
2006; 43: 257–68.
- 6
Santucci B,
Canistracci C,
Cristaudo A,
Camera E,
Picardo P.
Thimerosal positives: the role of organomercury alkyl compounds.
Contact Dermatitis
1998; 38: 325–8.
- 7
Yao CP,
Allen JW,
Aschner M.
Metallothioneins attenuate methylmercury-induced neurotoxicity in cultured astrocytes and astrocytoma cells.
Ann N Y Acad Sci
1999; 890: 223–6.
